Abstract Introduction and Design Node dissection during esophagectomy is an important
aspect of esophageal cancer staging. Controversy remains as to how many nodes need to …

Objective: To determine whether adjuvant chemotherapy (AC) after neoadjuvant
chemoradiation and esophagectomy is associated with improved overall survival for patients …

Background The benefit of adjuvant treatment for esophageal cancer patients with positive
lymph nodes after induction therapy and esophagectomy is uncertain. This in-depth …

Aims Neoadjuvant chemotherapy (NAC) remains an important therapeutic option for
advanced oesophageal cancer (OC). Pathological tumour regression grade (TRG) may offer …

Objectives The study objectives were to identify variables associated with the use of
adjuvant chemotherapy among patients with node-positive esophageal cancer who …

Background Esophageal squamous cell carcinoma (ESCC) is the predominant type of
esophageal cancer and most clinically curable patients are diagnosed with locally advanced …

Background Intensive trimodality therapy is needed for locally advanced esophageal
squamous cell carcinoma (ESCC). However, some patients develop recurrence and die of …

Purpose This study aimed to investigate the efficacy of adjuvant chemotherapy after
neoadjuvant chemoradiotherapy (CCRTx) followed by surgery in patients with esophageal …

Background The aim of this study was to develop nomograms for predicting the risk of
locoregional recurrence or distant metastasis in esophageal cancer patients who were …

Background It remains unclear whether postoperative chemotherapy improves survival
among patients with esophageal squamous cell carcinoma who have undergone …